Harvard Geneticist George Church to Present at 13th Aging Research Drug Discovery Meeting
George Church, a prominent Harvard geneticist, is scheduled to deliver a featured presentation at the 13th Aging Research & Drug Discovery (ARDD) Meeting. The event will take place from October 1-3 at the David Rubenstein Treehouse at Harvard University in Boston, Massachusetts. Church's participation highlights the ongoing debate about whether biological aging can be treated as a modifiable medical process rather than an inevitable consequence of time. The meeting, organized by Insilico Medicine, aims to gather academic researchers, clinicians, biotechnology executives, pharmaceutical companies, entrepreneurs, and investors. Their collective goal is to translate discoveries in aging biology into effective therapies that can preserve health and function. Church is recognized for his foundational work in genome science, including pioneering efforts in genome sequencing, genome editing, synthetic biology, gene therapy, cellular reprogramming, and AI-based protein engineering. His contributions have significa...